The North America Biotin Supplement Market would witness market growth of 8.3% CAGR during the forecast period (2022-2028).
Biotin insufficiency can also be triggered by a genetic condition affecting biotin's metabolism capability. The most prevalent of these conditions is biotinidase deficiency. Insufficient activity of the biotinidase enzyme prevents the recycling of biotin from biocytin. Biotin transporter and carboxylase deficiencies are less common. The United States was the first nation that began screening newborns for biotinidase deficiency.
Today, several other nations similarly test newborns for this genetic condition. The treatment available as of present is the consumption of biotin supplement. The deficiency of biotinidase is a genetic defect resulting in a deficit of the enzyme responsible for biotin recycling.
The diagnosis of partial biotinidase impairment is calculated as 10% to 30% of average serum activity and the treatment for severe deficiency is oral administration of 5 to 20 mg daily. Reportedly, seizures resolve between hours to days, whereas other symptoms resolve within weeks. Both severe and mild biotinidase deficiency needs to be treated with biotin supplements for the rest of their lives.
As people age and confront rising healthcare costs, many Canadians are examining the relationship between diet and health. The functional food and dietary supplement industries seize opportunities through product development and product penetration. In Canada, the demand for sodium substitutions, trans fat replacements, allergen-free (especially gluten-free) foods, sugar alternatives, clean labeling, naturally derived phytochemicals, nutrigenomics, protein boosters, and innovative technologies is anticipated to increase. Therefore, the rising popularity of health boosting supplements is driving demand for biotin supplements and thus propels the growth of the market.
The US market dominated the North America Biotin Supplement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $200 million by 2028. The Canada market is poised to grow at a CAGR of 10.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.8% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Specialty Stores, Ecommerce and Supermarkets / Hypermarkets. Based on Product Form, the market is segmented into Capsules, Tablets, Gummies, Liquid, Soft Gels and Powder. Based on Application, the market is segmented into Hair Care, Skin Care, Nail Care and Pharmaceutical. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Biotin Supplement Market is Estimated to reach $952.6 Million by 2028, at a CAGR of 9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Church & Dwight Co., Inc., Nestle S.A., Nutraceutical Corporation, Life Extension Foundation Buyers Club, Inc., The Nature’s Bounty Co. (Kohlberg Kravis Roberts & Co. L.P.), Zhou Nutrition LLC (Nutraceutical International Corporation), NOW Foods, Inc., Vytalogy Wellness, L.L.C. (New Mountain Capital, LLC), Doctor's Best, Inc. (Xiamen Kingdomway Group), and Designs for Health, Inc.
By Distribution Channel
By Product Form
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
